Edges in Network
| Network | GSE16446_egf1520 - GSE16446 - SiGN-BN HC+Bootstrap |
| Network Description | Predicting the efficacy of anthracyclines in breast cancer (BC) patients: The results of the TOP trial |
| Node | EREG |
| Upstream (Parents) |
|---|
| (<<) ACTC1 → EREG |
| (<<) AREG → EREG |
| (<<) BAALC → EREG |
| (<<) ISLR → EREG |
| (<<) MIA3 → EREG |
| (<<) MMP15 → EREG |
| (<<) MUC2 → EREG |
| (<<) MXRA8 → EREG |
| (<<) MYCN → EREG |
| (<<) NFKBIZ → EREG |
| (<<) OBSCN → EREG |
| (<<) PDIA3 → EREG |
| (<<) PLCD3 → EREG |
| (<<) RELL2 → EREG |
| (<<) RPS28 → EREG |
| (<<) S100P → EREG |
| (<<) SOD3 → EREG |
| (<<) SPRR1A → EREG |
| (<<) TFF1 → EREG |
| (<<) TSC22D1 → EREG |
| Downstream (Children) |
|---|
| EREG → ARSJ (>>) |
| EREG → BCAR3 (>>) |
| EREG → GNAI1 (>>) |
| EREG → HYAL1 (>>) |
| EREG → LIF (>>) |
| EREG → SLC5A1 (>>) |
| EREG → TUBA8 (>>) |
